Latest Insider Transactions at Ligand Pharmaceuticals Inc (LGND)
This section provides a real-time view of insider transactions for Ligand Pharmaceuticals Inc (LGND). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of LIGAND PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of LIGAND PHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 01
2022
|
John L Higgins Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,922
+9.76%
|
-
|
|
Nov 01
2022
|
Sarah Boyce |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,004
-25.77%
|
-
|
|
Nov 01
2022
|
Matthew W Foehr |
SELL
Sale (or disposition) back to the issuer
|
Direct |
20,304
-11.13%
|
-
|
|
Nov 01
2022
|
Charles S Berkman |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,944
-33.39%
|
-
|
|
Nov 01
2022
|
Sunil Patel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,004
-3.37%
|
-
|
|
Nov 01
2022
|
Jennifer R. Cochran |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,004
-46.37%
|
-
|
|
Nov 01
2022
|
Matthew E Korenberg President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
27,714
+24.37%
|
-
|
|
Sep 16
2022
|
John L Higgins Director |
SELL
Open market or private sale
|
Direct |
3,000
-0.82%
|
$267,000
$89.35 P/Share
|
|
Sep 15
2022
|
John L Higgins Director |
SELL
Open market or private sale
|
Direct |
2,000
-0.54%
|
$180,000
$90.0 P/Share
|
|
Jun 30
2022
|
Matthew E Korenberg President & COO |
BUY
Other acquisition or disposition
|
Direct |
164
+0.31%
|
$12,300
$75.84 P/Share
|
|
Jun 30
2022
|
John L Higgins Director |
BUY
Other acquisition or disposition
|
Direct |
164
+0.04%
|
$12,300
$75.84 P/Share
|
|
Jun 29
2022
|
Jason Haas Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,750
+50.0%
|
-
|
|
Jun 10
2022
|
Stephen L Sabba Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,004
+3.71%
|
-
|
|
Jun 10
2022
|
Matthew E Korenberg President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
8,062
+13.34%
|
-
|
|
Jun 10
2022
|
John L Higgins Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,423
+5.24%
|
-
|
|
Jun 10
2022
|
Matthew W Foehr |
BUY
Grant, award, or other acquisition
|
Direct |
9,137
+4.77%
|
-
|
|
Jun 10
2022
|
Charles S Berkman |
BUY
Grant, award, or other acquisition
|
Direct |
5,375
+13.06%
|
-
|
|
Jun 10
2022
|
Sunil Patel |
BUY
Grant, award, or other acquisition
|
Direct |
1,004
+3.26%
|
-
|
|
Jun 10
2022
|
John L Lamattina Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,004
+3.66%
|
-
|
|
Jun 10
2022
|
John W Kozarich Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,004
+2.32%
|
-
|
|
Jun 10
2022
|
Nancy Ryan Gray Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,004
+17.58%
|
-
|
|
Jun 10
2022
|
Todd C Davis Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,004
+1.9%
|
-
|
|
Jun 10
2022
|
Jennifer R. Cochran |
BUY
Grant, award, or other acquisition
|
Direct |
1,004
+31.68%
|
-
|
|
Jun 10
2022
|
Sarah Boyce |
BUY
Grant, award, or other acquisition
|
Direct |
1,004
+20.49%
|
-
|
|
Jun 10
2022
|
Jason Aryeh Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,004
+1.42%
|
-
|
|
May 13
2022
|
Matthew W Foehr |
BUY
Open market or private purchase
|
Direct |
2,500
+1.42%
|
$205,000
$82.76 P/Share
|
|
May 09
2022
|
John L Higgins Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+2.24%
|
$168,000
$21.92 P/Share
|
|
Feb 28
2022
|
John W Kozarich Director |
SELL
Open market or private sale
|
Direct |
908
-2.16%
|
$92,616
$102.62 P/Share
|
|
Feb 28
2022
|
John W Kozarich Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,335
+14.83%
|
$88,020
$12.53 P/Share
|
|
Feb 15
2022
|
Matthew E Korenberg President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,407
-2.44%
|
$419,061
$123.68 P/Share
|
|
Feb 15
2022
|
John L Higgins Director |
SELL
Payment of exercise price or tax liability
|
Direct |
5,923
-0.57%
|
$728,529
$123.68 P/Share
|
|
Feb 15
2022
|
Matthew W Foehr |
SELL
Payment of exercise price or tax liability
|
Direct |
3,546
-0.68%
|
$436,158
$123.68 P/Share
|
|
Feb 15
2022
|
Charles S Berkman |
SELL
Payment of exercise price or tax liability
|
Direct |
1,578
-1.67%
|
$194,094
$123.68 P/Share
|
|
Jan 26
2022
|
Matthew W Foehr |
SELL
Payment of exercise price or tax liability
|
Direct |
5,125
-1.44%
|
$579,125
$113.68 P/Share
|
|
Jan 26
2022
|
Matthew W Foehr |
BUY
Grant, award, or other acquisition
|
Direct |
13,000
+3.55%
|
-
|
|
Jan 26
2022
|
Charles S Berkman |
SELL
Payment of exercise price or tax liability
|
Direct |
2,156
-3.21%
|
$243,628
$113.68 P/Share
|
|
Jan 26
2022
|
Charles S Berkman |
BUY
Grant, award, or other acquisition
|
Direct |
6,237
+8.72%
|
-
|
|
Jan 26
2022
|
John L Higgins Director |
SELL
Payment of exercise price or tax liability
|
Direct |
9,243
-1.3%
|
$1,044,459
$113.68 P/Share
|
|
Jan 26
2022
|
John L Higgins Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,166
+3.18%
|
-
|
|
Jan 26
2022
|
Matthew E Korenberg President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,628
-3.59%
|
$409,964
$113.68 P/Share
|
|
Jan 26
2022
|
Matthew E Korenberg President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
11,651
+10.76%
|
-
|
|
Nov 16
2021
|
John L Lamattina Director |
SELL
Open market or private sale
|
Direct |
4,835
-15.99%
|
$778,435
$161.86 P/Share
|
|
Nov 16
2021
|
John L Lamattina Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,835
+13.79%
|
$154,720
$32.3 P/Share
|
|
Nov 12
2021
|
John L Higgins Director |
SELL
Open market or private sale
|
Direct |
3,000
-0.89%
|
$480,000
$160.5 P/Share
|
|
Nov 11
2021
|
Matthew W Foehr |
SELL
Open market or private sale
|
Direct |
11,160
-6.28%
|
$1,819,080
$163.02 P/Share
|
|
Nov 11
2021
|
Matthew W Foehr |
BUY
Exercise of conversion of derivative security
|
Direct |
12,188
+3.26%
|
$743,468
$61.15 P/Share
|
|
Aug 04
2021
|
Matthew W Foehr |
BUY
Exercise of conversion of derivative security
|
Direct |
9,982
+2.77%
|
$529,046
$53.86 P/Share
|
|
Aug 04
2021
|
Matthew W Foehr |
SELL
Open market or private sale
|
Direct |
8,840
-5.1%
|
$963,560
$109.67 P/Share
|
|
Jul 12
2021
|
Jennifer R. Cochran |
BUY
Grant, award, or other acquisition
|
Direct |
1,161
+50.0%
|
-
|
|
Jun 30
2021
|
Matthew E Korenberg President & COO |
BUY
Other acquisition or disposition
|
Direct |
247
+0.62%
|
$20,995
$85.91 P/Share
|